Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study ; volume:2 ; number:3 ; day:24 ; month:6 ; year:2011 ; pages:123-132 ; date:9.2011
Diabetes therapy ; 2, Heft 3 (24.6.2011), 123-132, 9.2011
- Urheber
-
Carlson, Glenn F.
Tou, Conrad K. P.
Parikh, Shamik
Birmingham, Bruce K.
Butler, Kathleen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-011-0003-2
- URN
-
urn:nbn:de:101:1-2023051122414106032726
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Carlson, Glenn F.
- Tou, Conrad K. P.
- Parikh, Shamik
- Birmingham, Bruce K.
- Butler, Kathleen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study
The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects
Thorough!
Dapagliflozin
Evaluation of the impact of lopinavir/ritonavir (LPV/r) and ritonavir (RTV) on QTcF: results of a thorough QT study
A thorough evaluation of RAMBAM
Evaluation of the impact of lopinavir/ritonavir (LPV/r) and ritonavir (RTV) on PR interval: results from a thorough QT study
Identification and characterization of gene variants associated with cardiac repolarization (QT interval)
Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study
The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects
Thorough!
Dapagliflozin
Evaluation of the impact of lopinavir/ritonavir (LPV/r) and ritonavir (RTV) on QTcF: results of a thorough QT study
A thorough evaluation of RAMBAM
Evaluation of the impact of lopinavir/ritonavir (LPV/r) and ritonavir (RTV) on PR interval: results from a thorough QT study
Identification and characterization of gene variants associated with cardiac repolarization (QT interval)
Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study
The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects
Thorough!
Dapagliflozin
Evaluation of the impact of lopinavir/ritonavir (LPV/r) and ritonavir (RTV) on QTcF: results of a thorough QT study
A thorough evaluation of RAMBAM
Evaluation of the impact of lopinavir/ritonavir (LPV/r) and ritonavir (RTV) on PR interval: results from a thorough QT study
Identification and characterization of gene variants associated with cardiac repolarization (QT interval)
Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK